Germany to India: Extract Import Trade Route

The Germany to India Extract corridor is one of India's established pharmaceutical import routes from Germany, with 16 shipments documented worth a combined $90.3M USD. The route is dominated by Dr Willmar Schwabe GmbH Co KG, which alone accounts for roughly 100% of all import value, reflecting the consolidated nature of Germany's extract export sector.

Across 4 active Germany suppliers, the average shipment value stands at $5.6M USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 81% of all shipments, consistent with extract's non-urgent bulk-order profile.

Shipment activity peaks during July–September, with an average transit time of 15 days port-to-port. The route has recorded an annual growth rate of 30.5%, placing it at rank #15 among India's top extract import origins globally.

On the Indian buyer side, key Indian importers include DR WILLMAR SCHWABE INDIA PRIVATE LIMITED, DR WILLMAR SCHWABE INDIA PRIVATE LIMITED , DR WILLMAR SCHWABE INDIA PVT LTD and 2 others. DR WILLMAR SCHWABE INDIA PRIVATE LIMITED is the single largest Indian importer with 8 shipments valued at $90.0M USD.

India's extract imports from Germany are driven primarily by a handful of large-scale Germany manufacturers. Dr Willmar Schwabe GmbH Co KG with 11 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 4 active exporters signals a competitive but concentrated market — Indian buyers benefit from Germany supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — Dr Willmar Schwabe GmbH Co KG, Dr. Willmar Schwabe GmbH & Co. KG, HANSE BIOPHARMA GMBH — together account for 100% of total trade value on this route. The average shipment value of $5.6M USD reflects primarily bulk commercial orders from large pharmaceutical distributors.

Beyond the primary product category, shipments on this route include closely related formulations such as tebokan ginkgo biloba extract 40 mg tablet batch no-0870923 finished formulation and tebokan forte ginkgo biloba extract 120mg tablet batch no-397593513/0650923 finished formulation, suggesting that Indian buyers tend to consolidate orders across related product lines from the same Germany supplier.

On the buying side, DR WILLMAR SCHWABE INDIA PRIVATE LIMITED is the largest importer with 8 shipments worth $90.0M USD — representing 100% of all extract imports from Germany on this route.